Literature DB >> 16797258

Chiral separation and quantification of R/S-amphetamine, R/S-methamphetamine, R/S-MDA, R/S-MDMA, and R/S-MDEA in whole blood by GC-EI-MS.

Louise Bang Rasmussen1, Kristine Høje Olsen, Sys Stybe Johansen.   

Abstract

The enantioselective composition of the amphetamines is of interest, as the enantiomers show differences in their pharmacological effects and several methods for chiral separation of amphetamines have been described. Only a few methods have used whole blood as matrix and none of these separates both classic amphetamines (amphetamine and methamphetamine) and designer amphetamines (MDA, MDMA and MDEA). The aim of this study was, therefore, to develop a method for enantioselective analysis of AM, MA, MDA, MDMA, and MDEA in whole blood. The amphetamines were extracted from 0.5 g of whole blood by liquid-liquid extraction. After derivatization with R-MTPCl, the resulting diastereomers were separated by GC on a HP-5MS column and detected by SIM-MS. R-MTPCl was used as derivatization reagent because of the stability of this reagent and good separation of these analytes. Through the method, development time and temperature of the derivatization were optimized, and by admixture of 0.02% triethylamine it became possible to detect the amphetamines in adequately low concentrations as more analytes were derivatized. The method was validated and it was linear from 0.004 to 3 microg/g per enantiomer. The accuracy was within 91-115%, while the repeatability and reproducibility were < or =15% R.S.D. A method suitable for enantioselective separation and analysis of the amphetamines has been achieved, and the method was applied to analysis of whole blood samples originating from traffic and criminal cases and post mortem cases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16797258     DOI: 10.1016/j.jchromb.2006.05.011

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  7 in total

1.  Determination of the unbound fraction of R- and S-methadone in human brain.

Authors:  Karen M D Holm; Kristian Linnet
Journal:  Int J Legal Med       Date:  2016-04-07       Impact factor: 2.686

2.  Chiral Recognition Mechanisms of four β-Blockers by HPLC with Amylose Chiral Stationary Phase.

Authors:  Dongmei Wang; Fang Li; Zhen Jiang; Li Yu; Xingjie Guo
Journal:  Iran J Pharm Res       Date:  2014       Impact factor: 1.696

3.  Chiral enantioresolution of cathinone derivatives present in "legal highs", and enantioselectivity evaluation on cytotoxicity of 3,4-methylenedioxypyrovalerone (MDPV).

Authors:  Bárbara Silva; Carla Fernandes; Maria Elizabeth Tiritan; Madalena M M Pinto; Maria João Valente; Márcia Carvalho; Paula Guedes de Pinho; Fernando Remião
Journal:  Forensic Toxicol       Date:  2016-06-13       Impact factor: 4.096

4.  Enantioseparation and Determination of Mephedrone and Its Metabolites by Capillary Electrophoresis Using Cyclodextrins as Chiral Selectors.

Authors:  Pavel Řezanka; Denisa Macková; Radek Jurok; Michal Himl; Martin Kuchař
Journal:  Molecules       Date:  2020-06-23       Impact factor: 4.411

5.  Chiral separation of cathinone derivatives using β-cyclodextrin-assisted capillary electrophoresis-Comparison of four different β-cyclodextrin derivatives used as chiral selectors.

Authors:  Johannes S Hägele; Eva-Maria Hubner; Martin G Schmid
Journal:  Electrophoresis       Date:  2019-06-04       Impact factor: 3.535

Review 6.  Chiral Drug Analysis in Forensic Chemistry: An Overview.

Authors:  Cláudia Ribeiro; Cristiana Santos; Valter Gonçalves; Ana Ramos; Carlos Afonso; Maria Elizabeth Tiritan
Journal:  Molecules       Date:  2018-01-28       Impact factor: 4.411

7.  Determination of the chiral status of different novel psychoactive substance classes by capillary electrophoresis and β-cyclodextrin derivatives.

Authors:  Johannes S Hägele; Eva-Maria Hubner; Martin G Schmid
Journal:  Chirality       Date:  2020-07-15       Impact factor: 2.437

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.